Home › Pharmacy › Daniel Mickool, R.Ph, M.S., Ed.D

Daniel Mickool, R.Ph, M.S., Ed.D

Pharmacy

Last researched 3 months ago

Pharmacy Oncology Internal Medicine

About

Daniel Mickool is a pharmacist and educator holding a Doctor of Education degree alongside graduate-level training in the pharmaceutical sciences. His credentials reflect a career that bridges clinical pharmacy practice and academic or instructional work.

He holds the R.Ph. designation, indicating licensure as a registered pharmacist, and his M.S. and Ed.D. degrees suggest sustained engagement with both the scientific and educational dimensions of the field.

Publications

A randomized, multicenter Phase II trial to compare prophylaxis of graft versus host disease with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamide.
A promising therapeutic biomaterial: CHX@ZnO-HA/PSSS nanocomposites enable pH-Dependent infection eradication and bone regeneration in osteomyelitis.
To gain insights into heat adaptations among women during the antenatal period in India -The Heat in Pregnancy Project (HiP-I) India- Qualitative Study Protocol.
Molecular Pathways and Therapeutic Frontiers in Cancer Cachexia: Integrating Inflammatory and Non-Inflammatory Mechanisms.
Fasting safely during Ramadan with diabetes: clinical practice recommendations for Arab populations from the Arab Diabetes Forum (FSR-ADF).
Reproductive experience modifies the dopaminergic system of postpartum estrous rats: changes in the sensitivity to the behavioural effects of sch-23390 and in its receptors' binding.
NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A Pilot Study.
Complete hydatidiform mole with a co-existing normal fetus at mid-trimester in a dichorionic diamniotic gestation.
Surgical Surprise and a Ryle's Tube Misadventure: An Intraoperative Gastric Perforation.
Molecular mastery: Harnessing DNA technology for disease prevention.